专科狼疮门诊经验:初发与现患狼疮肾炎队列的表现及损伤结局比较
该纵向专科狼疮门诊研究纳入526例狼疮肾炎患者,比较发病1年内入组的初发队列(n=246)与后期转诊的现患队列(n=280)。中位随访8.3年,两队列肾脏损伤结局无显著差异,但初发队列肾外损伤累积风险显著降低(校正HR 0.67,p=0.04)。
要点
- 现患队列慢性指数更高(中位3.0 vs 2.0,p<0.01)且免疫抑制使用更频繁(89.6% vs 81.3%,p=0.01)。
- 肾脏复合损伤结局两队列无显著差异(18.9% vs 22.9%,p=0.32;校正HR 1.00,p=0.99)。
- 初发队列肾外损伤累积风险显著低于现患队列(校正HR 0.67,p=0.04)。
核心结论
- 狼疮肾炎患者肾脏与非肾脏损伤均高发,早期入组初发队列可显著降低肾外损伤累积风险。
研究设计与样本
- 纵向专科狼疮门诊队列研究,分析526例患者首次记录的狼疮肾炎事件,分为初发队列(n=246,发病1年内入组)与现患队列(n=280,后期转诊)。
主要发现
- 两队列基线肾功能和LN病理分型相似,但现患队列慢性指数更高(中位3.0 vs 2.0,p<0.01)且免疫抑制使用更频繁(251/280 [89.6%] vs 200/246 [81.3%],p=0.01)。
- 中位随访8.3年,肾脏复合损伤结局(终末期肾病或eGFR持续下降≥40%)发生率初发队列46/244 [18.9%]、现患队列63/275 [22.9%],两组无显著差异(p=0.32;校正HR 1.00,p=0.99)。
- 初发队列肾外损伤累积风险显著低于现患队列(校正HR 0.67,p=0.04)。
关键数值与推荐
- 肾脏复合损伤结局定义为终末期肾病或eGFR持续下降≥40%。
- 肾外损伤累积定义为非肾脏SLICC/ACR损伤指数(SDI)增加。
临床怎么用
- 狼疮肾炎患者应重视肾外损伤的监测与预防,早期识别和转诊可能减少肾外损伤累积。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to compare clinical presentations and damage outcomes of lupus nephritis (LN) between patients enrolled early in their systemic lupus erythematosus (SLE) disease course (inception cohort, within one year of disease diagnosis) and those referred later (prevalent cohort). METHODS: We analyzed 526 patients from a longitudinal specialized lupus clinic, focusing on their initial documented LN event, and classified them as inception (n = 246) or prevalent (n = 280) cohorts. Baseline demographics, renal parameters, serologies, histopathology, and treatments were compared. Primary outcomes included a composite renal damage outcome (end-stage kidney disease or a sustained ≥40% eGFR decline) and extra-renal damage accrual (increase in non-renal SLICC/ACR Damage Index [SDI]). Cox proportional hazards models adjusted for confounders assessed associations between cohort status and outcomes. RESULTS: Baseline renal function and LN histologic class were similar between cohorts, though the prevalent group had a higher chronicity index (median 3.0 vs. 2.0, p < 0.01) and more frequent immunosuppressive use (251/280 [89.6%] vs. 200/246 [81.3%], p = 0.01). Renal damage outcomes did not significantly differ between cohorts over a median follow-up of 8.3 years, occurring in 46/244 inception patients [18.9%] and 63/275 prevalent patients [22.9%] (p = 0.32; adjusted HR 1.00, p = 0.99). However, inception cohort patients showed a significantly reduced risk of extra-renal damage accrual (adjusted HR 0.67, p = 0.04). CONCLUSIONS: Renal and non-renal damage are highly prevalent in LN patients. Extra-renal damage is greater in the prevalent cohort, likely reflecting prior disease activity and higher cumulative exposure to immunosuppressive therapies, particularly glucocorticoids, before clinic entry.
引用
- Kharouf F, Mehta P, Li Q, et al. Lessons from a specialized lupus clinic: Presentation and damage outcomes in inception vs. prevalent lupus nephritis cohorts. Semin Arthritis Rheum. 2026. PMID: 42766980. doi:10.1016/j.semarthrit.2026.153074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。